A glycomics approach to the discovery of potential cancer biomarkers.

Hyun Joo An, Carlito B Lebrilla

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Glycosylation is highly sensitive to the biochemical environment and plays a key role in development and disease manifestation. Moreover, glycan biosynthesis depends on several highly competitive processes; thus, variations in the concentration of specific glycosyltransferases produce different products. For this reason, monitoring changes in glycosylation may be a more specific and sensitive approach to biomarker discovery and possibly disease diagnosis. Glycans in serum are of particular interest as approximately half of all proteins are glycosylated. We have developed the methods for profiling the glycans in human serum to identify glycan biomarker. Global release methods were used including chemical and enzymatic to access O-linked and N-linked glycans, respectively. Glycans were released from the culture medium of various cancer cell lines, in control sera, and in cancer patients and isolated using solid phase extraction (SPE) with a porous graphitized carbon. The SPE fractions were analyzed by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry (MALDI FTICR MS). Glycan compositions were determined based on accurate masses and tandem mass spectrometry. Glycosylation changes between control and patient group were monitored. Several glycans were identified as potential markers for ovarian, breast, and prostate cancer. In short, direct glycan analysis of human serum without any protein identification represents a new and innovative approach to disease marker discovery.

Original languageEnglish (US)
Pages (from-to)199-213
Number of pages15
JournalMethods in molecular biology (Clifton, N.J.)
Volume600
StatePublished - 2010

Fingerprint

Glycomics
Tumor Biomarkers
Polysaccharides
Glycosylation
Solid Phase Extraction
Serum
Biomarkers
Cyclotrons
Glycosyltransferases
Fourier Analysis
Tandem Mass Spectrometry
Ovarian Neoplasms
Culture Media
Mass Spectrometry
Neoplasms
Prostatic Neoplasms
Proteins
Lasers
Carbon
Ions

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A glycomics approach to the discovery of potential cancer biomarkers. / An, Hyun Joo; Lebrilla, Carlito B.

In: Methods in molecular biology (Clifton, N.J.), Vol. 600, 2010, p. 199-213.

Research output: Contribution to journalArticle

@article{69077129475340908d2dfdf7ef860b20,
title = "A glycomics approach to the discovery of potential cancer biomarkers.",
abstract = "Glycosylation is highly sensitive to the biochemical environment and plays a key role in development and disease manifestation. Moreover, glycan biosynthesis depends on several highly competitive processes; thus, variations in the concentration of specific glycosyltransferases produce different products. For this reason, monitoring changes in glycosylation may be a more specific and sensitive approach to biomarker discovery and possibly disease diagnosis. Glycans in serum are of particular interest as approximately half of all proteins are glycosylated. We have developed the methods for profiling the glycans in human serum to identify glycan biomarker. Global release methods were used including chemical and enzymatic to access O-linked and N-linked glycans, respectively. Glycans were released from the culture medium of various cancer cell lines, in control sera, and in cancer patients and isolated using solid phase extraction (SPE) with a porous graphitized carbon. The SPE fractions were analyzed by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry (MALDI FTICR MS). Glycan compositions were determined based on accurate masses and tandem mass spectrometry. Glycosylation changes between control and patient group were monitored. Several glycans were identified as potential markers for ovarian, breast, and prostate cancer. In short, direct glycan analysis of human serum without any protein identification represents a new and innovative approach to disease marker discovery.",
author = "An, {Hyun Joo} and Lebrilla, {Carlito B}",
year = "2010",
language = "English (US)",
volume = "600",
pages = "199--213",
journal = "Methods in molecular biology (Clifton, N.J.)",
issn = "1064-3745",
publisher = "Humana Press",

}

TY - JOUR

T1 - A glycomics approach to the discovery of potential cancer biomarkers.

AU - An, Hyun Joo

AU - Lebrilla, Carlito B

PY - 2010

Y1 - 2010

N2 - Glycosylation is highly sensitive to the biochemical environment and plays a key role in development and disease manifestation. Moreover, glycan biosynthesis depends on several highly competitive processes; thus, variations in the concentration of specific glycosyltransferases produce different products. For this reason, monitoring changes in glycosylation may be a more specific and sensitive approach to biomarker discovery and possibly disease diagnosis. Glycans in serum are of particular interest as approximately half of all proteins are glycosylated. We have developed the methods for profiling the glycans in human serum to identify glycan biomarker. Global release methods were used including chemical and enzymatic to access O-linked and N-linked glycans, respectively. Glycans were released from the culture medium of various cancer cell lines, in control sera, and in cancer patients and isolated using solid phase extraction (SPE) with a porous graphitized carbon. The SPE fractions were analyzed by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry (MALDI FTICR MS). Glycan compositions were determined based on accurate masses and tandem mass spectrometry. Glycosylation changes between control and patient group were monitored. Several glycans were identified as potential markers for ovarian, breast, and prostate cancer. In short, direct glycan analysis of human serum without any protein identification represents a new and innovative approach to disease marker discovery.

AB - Glycosylation is highly sensitive to the biochemical environment and plays a key role in development and disease manifestation. Moreover, glycan biosynthesis depends on several highly competitive processes; thus, variations in the concentration of specific glycosyltransferases produce different products. For this reason, monitoring changes in glycosylation may be a more specific and sensitive approach to biomarker discovery and possibly disease diagnosis. Glycans in serum are of particular interest as approximately half of all proteins are glycosylated. We have developed the methods for profiling the glycans in human serum to identify glycan biomarker. Global release methods were used including chemical and enzymatic to access O-linked and N-linked glycans, respectively. Glycans were released from the culture medium of various cancer cell lines, in control sera, and in cancer patients and isolated using solid phase extraction (SPE) with a porous graphitized carbon. The SPE fractions were analyzed by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry (MALDI FTICR MS). Glycan compositions were determined based on accurate masses and tandem mass spectrometry. Glycosylation changes between control and patient group were monitored. Several glycans were identified as potential markers for ovarian, breast, and prostate cancer. In short, direct glycan analysis of human serum without any protein identification represents a new and innovative approach to disease marker discovery.

UR - http://www.scopus.com/inward/record.url?scp=74049087478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74049087478&partnerID=8YFLogxK

M3 - Article

C2 - 19882130

AN - SCOPUS:74049087478

VL - 600

SP - 199

EP - 213

JO - Methods in molecular biology (Clifton, N.J.)

JF - Methods in molecular biology (Clifton, N.J.)

SN - 1064-3745

ER -